2 hours ago • thepharmaletter.com
Incyte wins European approval of Minjuvi in FL
2 hours ago • thepharmaletter.com
Incyte wins European approval of Minjuvi in FL2025-12-17 • PR Newswire
Antengene Expands XPOVIO® Indications in Malaysia with Approval in Diffuse Large B-cell Lymphoma2025-12-16 • biotechdispatch.com.au
Prescient secures European approval to launch PTX-100 trial for rare lymphoma2025-12-13 • targetedonc.com
FDA Grants Priority Review to Nivolumab-AVD in Classical Hodgkin Lymphoma2025-12-13 • miragenews.com
CAR-T Therapy Boosts Long-Term Lymphoma Survival2025-12-13 • consultqd.clevelandclinic.org
Researchers Identify Predictors of Response to CAR T-Cell Therapy in B-Cell Non-Hodgkin’s Lymphoma2025-12-10 • quiverquant.com
Corvus Pharmaceuticals Reports Promising Phase 1 Data for Soquelitinib in Relapsed/Refractory T Cell Lymphoma at ASH Annual Meeting2025-12-10 • medicalxpress.com
New combination approach aims to make CAR T more durable in lymphoma2025-12-09 • abc4.com
Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition2025-12-09 • gurufocus.com
Eli Lilly (LLY) Reports Positive Results from Jaypirca Phase 3 Trial2025-12-09 • stocktitan.net
Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition2025-12-09 • pharmiweb.com
Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma2025-12-08 • quiverquant.com
Arvinas, Inc. Announces Phase 1 Clinical Trial Initiation for ARV-393 Plus Glofitamab in Diffuse Large B-Cell Lymphoma Following Promising Preclinical Data2025-12-08 • globenewswire.com
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)2025-12-06 • PR Newswire
Vivacta Bio Announces Promising First-in-Human Results for GT801, an In Vivo CAR-T Therapy, in Non-Hodgkin's Lymphoma at the 2025 ASH Annual Meeting2025-12-03 • PR Newswire
Foresight Diagnostics Announces Multiple Presentations in Lymphoma Featuring PhasED-Seq™ Ultrasensitive MRD Analysis at the upcoming ASH Annual Meeting2025-12-03 • PR Newswire
ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA® in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma2025-12-03 • PR Newswire
XPOVIO® Approved in Hong Kong for Two Additional Indications in Multiple Myeloma and Diffuse Large B-Cell Lymphoma2025-12-03 • PR Newswire
Blood Cancer United, formerly The Leukemia & Lymphoma Society, Announces New Funding for Lifesaving Cancer Breakthroughs2025-12-02 • drugdiscoverytrends.com
First FDA-approved treatment for lymphoma (CTCL) in seven years2025-12-01 • PR Newswire
Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)2025-12-01 • PR Newswire
Blood Cancer United Showcases Bold Research and Vision at 2025 ASH Annual Meeting2025-11-28 • onclive.com
FDA Grants Priority Review to Sonrotoclax for R/R Mantle Cell Lymphoma2025-11-28 • PR Newswire
Inaticabtagene Autoleucel (YORWIDATM) New Drug Application for Lymphoma Approved, China's innovative CAR-T Enters a New Era of Dual Indications2025-11-28 • cancernetwork.com
Sonrotoclax Earns FDA Priority Review in R/R Mantle Cell Lymphoma2025-11-26 • businesswireindia.com
U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma2025-11-26 • EIN Presswire
Non Hodgkin Lymphoma (NHL) Global Market Report 2025| Business Growth, Current and Future Trends till 20292025-11-19 • PR Newswire
Soligenix Achieves Enrollment Milestone for Planned Interim Analysis in Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma2025-11-19 • PR Newswire
AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular LymphomaJust now • newswire.ca
STATEMENT - Bill 2 in Quebec: CMA welcomes acceptance of tentative agreement with FMOQJust now • newswire.ca
Latest BC floods a reminder that governments must invest more in resilience60 minutes ago • prnewswire.co.uk
Commercial Energy as a Service Market worth $55.04 billion by 2030 | MarketsandMarkets™1 hour ago • mlive.com
Months of construction ahead as Ann Arbor undertakes $20M sewer project1 hour ago • juniorminingnetwork.com
McFarlane Lake Mining Commences Exploration Drilling at Juby Gold Project1 hour ago • manufacturingdive.com
Hyundai Steel brings in $582M Posco investment for Louisiana mill1 hour ago • dtnext.in
RBI data proof for agricultures decadal decline under DMK: Anbumani1 hour ago • trend.az
Turkmengas announces tender for technological equipment and chemical products1 hour ago • argaam.com
Edaa implements corporate action on Saudi Government SAR Sukuk Securities1 hour ago • caixinglobal.com
CATL Tests Humanoid Robots on Battery Production Lines1 hour ago • eso.org
Construction begins on the first and largest gamma-ray observatory in Chile1 hour ago • newelectronics.co.uk
AGS Devices integrates CELUS Platform to speed up electronics design and procurementJust now • PR Newswire
Cboe Congratulates Michael Selig on Confirmation as CFTC ChairmanJust now • PR Newswire
SIPs Submit Plan Amendment to Extend Operating Hours to Accommodate Overnight TradingJust now • PR Newswire
BRC Therapeutics Applauds Executive Order to Reclassify Cannabis4 hours ago • tradingview.com
SovEcon lifts Russia’s 2025 wheat forecast to 88.8 MMT, flags drop next year1 hour ago • www1.ru
Agricultural machinery manufacturer KRMZ launches robotic welding complex4 hours ago • armyrecognition.com
Russia Deploys S-500 Missile Defense System on Combat Duty for the First Time.1 hour ago • dtnext.in
RBI data proof for agricultures decadal decline under DMK: Anbumani1 hour ago • indianexpress.com
Haryana Vidhan Sabha winter session: Over 25 lakh farmers have Rs 60,816 crore outstanding loans, says CM Nayab Singh Saini1 hour ago • therealtytoday.com
Delhi Government Plans Major Revision of Agricultural Land Circle Rates with Up to Eight-Fold Hike30 minutes ago • EIN Presswire
School Absence Linked to Sharp Rise in Children’s Mental Health Risks, Study Finds1 hour ago • artificialintelligence-news.com
AstraZeneca leads big pharma’s AI clinical trials revolution with real-world patient impact1 hour ago • bbc.com
Charity to get new building after long 'struggle'Stay ahead with real-time headlines from top sources, categorized by sector and country.